In this approach, researchers can simply transfect their preferred host cell—in most cases, human embryonic kidney (HEK) 293 cells—with all three plasmids in a stepwise procedure (see Figure 1).

The management of breast cancer involves various therapeutic approaches. However, many current anticancer treatments indiscriminately damage both cancerous and healthy cells. In cancer treatment, ...